ZURICH (Reuters) – Johnson & Johnson’s <JNJ.N> Cilag Holding will offer up to approximately 11.8 million existing ordinary shares in Idorsia Ltd <IDIA.S> in an accelerated bookbuilding to commence on Wednesday, the transaction’s bookrunner said.

The sale corresponds to approximately 8.3% of Swiss drugmaker Idorsia’s outstanding ordinary share capital. Goldman Sachs <GS.N> will act as sole bookruner on the sale.

(Reporting by Brenna Hughes Neghaiwi; Editing by Michael Shields)